Aged > 65 years taking antihypertensives | Aged > 65 years not taking antihypertensives | |||
---|---|---|---|---|
Crude OR (95% CI) | Adjusted OR (95% CI) | Crude OR (95% CI) | Adjusted OR (95% CI) | |
A. Prediction of MT | ||||
Male sex | 1.60 (0.64–4.02) | 2.51 (0.09–72.7) | 2.12 (1.00–4.43) | 0.68 (0.16–2.99) |
Age, yr | 0.95 (0.88–1.02) | 1.13 (0.91–1.40) | 1.02 (0.96–1.07) | 0.99 (0.88–1.11) |
Prehospital SBP | ||||
< 90 mmHg | 95.7* (4.78–194) | 94.0* (4.16–795) | 6.38 (0.67–61.1) | 1.02 (0.95–2.25) |
90–110 mmHg | 28.7* (2.49–133) | 28.1* (1.75–52.0) | 10.8* (3.17–32.0) | 2.37 (0.48–11.7) |
> 110 mmHg | 1.00 | 1.00 | 1.00 | 1.00 |
SI > 1.0. ED | 20.7* (7.48–57.2) | 8.04 (0.17–83.8) | 23.9* (11.6–49.1) | 10.3* (2.27–46.3) |
RTS | 0.52* (0.37–0.77) | 0.35 (0.10–1.16) | 0.33* (0.26–0.43) | 0.49* (0.28–0.87) |
ISS | 1.09* (1.05–1.14) | 1.08 (0.96–1.22) | 1.10* (1.06–1.14) | 1.02 (0.93–1.12) |
B. 30-day mortality | ||||
Male sex | 1.01 (0.60–1.71) | 0.29 (0.07–1.25) | 2.09* (1.29–3.37) | 1.00 (0.31–3.28) |
Age, yr | 1.00 (0.96–1.03) | 1.08 (0.98–1.19) | 1.00 (0.97–1.03) | 0.99 (0.92–1.08) |
Prehospital SBP | ||||
< 90 mmHg | 5.00 (0.50–50.5) | 1.00 (0.06–12.0) | 4.56 (0.80–26.1) | 1.01 (0.26–11.0) |
90–110 mmHg | 1.50 (0.33–6.93) | 2.69 (0.44–16.6) | 2.88* (1.06–7.85) | 0.79 (0.17–3.72) |
> 110 mmHg | 1.00 | 1.00 | 1.00 | 1.00 |
SI > 1.0. ED | 7.96* (3.61–17.5) | 0.80 (0.04–17.1) | 3.05* (1.51–6.17) | 0.06* (0.01–0.56) |
RTS | 0.30* (0.22–0.39) | 0.45* (0.28–0.71) | 0.28* (0.22–0.36) | 0.33* (0.21–0.53) |
ISS | 1.18* (1.14–1.22) | 1.12* (1.05–1.20) | 1.15* (1.21–1.18) | 1.09* (1.02–1.16) |